CTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Captor Therapeutics SA

Watchlist Manager

Watchlist

Price: 72.4 PLN -0.14% Market Closed

Market Cap: zł459.7m

C	Captor Therapeutics SA WSE:CTX	PL
E	Expand Energy Corp F:CS1	US
	Arcosa Inc NYSE:ACA	US
	Prosegur Compania de Seguridad SA F:PRHA	ES
G	Gen Digital Inc DUS:SYM	US
S	Sally Beauty Holdings Inc F:S7V	US
H	Hormel Foods Corp XMUN:HO7	US
F	F5 Inc SWB:FFV	US
	Cognizant Technology Solutions Corp NASDAQ:CTSH	US
A	Autoliv Inc XMUN:LIV	SE
M	Mitsubishi UFJ Financial Group Inc DUS:MFZ	JP
	Northeast Community Bancorp Inc F:JY4	US

Profitability Summary

Captor Therapeutics SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

76%

Strong 3Y Average Gross Margin

62%

Declining Gross Margin

84% > 76%

Negative Operating Margin

-1 852%

Negative 3Y Average Operating Margin

-566%

Declining Operating Margin

-579% > -1 852%

Negative Net Margin

-1 791%

Negative 3Y Average Net Margin

-549%

Declining Net Margin

-539% > -1 791%

Negative Free Cash Flow Margin

-3 072%

Negative 3Y Average Free Cash Flow Margin

-519%

Declining Free Cash Flow Margin

-397% > -3 072%

Negative ROE

-110%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-460%

Declining ROIC

-507% > -759%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.